In the U.S., health care is a commodity, and cancer, a billion dollar industry. Standard conventional cancer treatments include surgery, chemotherapy and radiation, even though these treatments are toxic and do not work. Apple visionary Steve Jobs died at age 56 from pancreatic cancer: Jobs could change the world, but could not save his own life. It does not matter how famous you are or how much money you have, mainstream cancer treatments kill.

In Innocent Casualties, the reader will discover how a 73-year-old woman survived metastatic breast cancer with ozone treatments. Ozone destroys cancer cells and tumors, however, ozone machines are not legal in the U.S., since ozone cannot be patented. In a complementary health care system -- combining non-toxic alternative treatments with mainstream treatments that work -- heart disease, cancer, and diabetes can be cured or treated as chronic illnesses, rather than as death sentences.  Vitamins and herbs can help, instead of misleading headlines claiming that vitamins are dangerous.

Read Innocent Casualties to discover how the American medical establishment has evolved into an "undercover dictatorship,” and to demand every citizen’s constitutional right to freedom of choice in health care.

Vioxx is the RX drug that has been in the news the most since 2004. Merck, the billion dollar pharmaceutical company, as well as the FDA, did not disclose the high risk of heart attacks or strokes which accompanied this arthritic painkiller. Dr Steven Nissen, interim Chairman of Cardiology at the highly regarded Cleveland Clinic, reported that Merck intentionally misrepresented an analysis of data from a follow-up review of patients involved in the clinical trial that resulted in pulling Vioxx from the market. Dr. Nissen warned: "It's important that we inform people about this because patients who have taken the drug will need increased surveillance by their physicians and increased awareness of their risks in the year subsequent to stopping the drug. And that risk may extend beyond a year; we simply don't know."

In the September 2004, Merck was forced to take Vioxx off the market after a three-year study demonstrated that Vioxx doubled the risk of heart attacks and strokes in patients taking it for at least eighteen months.

A May 2006 study in the Canadian Medical Association Journal states that Vioxx may raise the risk of heart attacks for patients who took the drug for less than two weeks: More than 25 percent of 239 patients who had heart attacks did so in less than thirteen days of being on the drug.

There are thousands of lawsuits from people who claim to have adverse heart problems in 2005, and Merck was unable to counter the data that Dr. Nissen exposed. Merck’s attorneys insist that the one-year follow-up data should protect Merck from lawsuits filed by people who suffered heart attacks or strokes after they had stopped taking Vioxx. However, Nissen countered Merck’s claim: "What counts is the relative risk as you go forward, and the bottom line is there is a constant risk even after the drug is stopped." A year after stopping the medication, Merck insisted that patients who took Vioxx in their clinical study had no greater risk of heart attacks or strokes than those who took placebos. Although there were twenty-eight heart attacks or strokes in the Vioxx group compared to sixteen in the placebo group, Merck claimed that those numbers were not statistically significant.

Dr. Nissen has patient data documentation which proves that Merck’s information is total fabrication: "In the one year after Vioxx was stopped there was a 75 percent greater risk of having an adverse event. What this means is that, surprisingly, in the year following discontinuation of Vioxx the relative risk remained approximately as high as it was when people were actually taking the drug. That is very clear from the data. What is important is that the hazard stays constant even after you stop the drug."

Read more.. http://www.fdainformation.com/